Inventor
POLSON ANDREW
US43 patents
⚠️ This page may combine multiple inventors who share the name “POLSON ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
33 patentsUS9896506B2Feb 20, 2018
Anti-CD79B antibodies and immunoconjugates and methods of use
GENENTECH INC17 citations94
US8617559B2Dec 31, 2013
Anti-FcRH5 antibodies and immunoconjugates and methods of use
GENENTECH INC19 citations92
US8362213B2Jan 29, 2013
Anti-FcRH5 antibodies and immunoconjugates and methods of use
GENENTECH INC28 citations92
US7888478B2Feb 15, 2011
Compositions and methods for the treatment of tumor of hematopoietic origin
GENENTECH INC15 citations92
US10494432B2Dec 3, 2019
Anti-CD79B antibodies and immunoconjugates and methods of use
GENENTECH INC5 citations84
US10150813B2Dec 11, 2018
Anti-B7-H4 antibodies and immunoconjugates
GENENTECH INC12 citations84
US10059768B2Aug 28, 2018
Anti-B7-H4 antibodies and immunoconjugates
GENENTECH INC9 citations84
US9951133B2Apr 24, 2018
Anti-CD33 antibodies and immunoconjugates
GENENTECH INC12 citations84
US9562099B2Feb 7, 2017
Anti-B7-H4 antibodies and immunoconjugates
GENENTECH INC16 citations84
US9975949B2May 22, 2018
Anti-CD79b antibodies and methods of use
GENENTECH INC13 citations83
US9695240B2Jul 4, 2017
Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
GENENTECH INC11 citations83
US9360484B2Jun 7, 2016
Anti-FcRH5 antibodies and immunoconjugates and methods of use
GENENTECH INC7 citations83
US9017951B2Apr 28, 2015
Anti-FcRH5 antibodies and immunoconjugates and methods of use
GENENTECH INC7 citations83
US7858330B2Dec 28, 2010
Compositions and methods for the treatment of tumor of hematopoietic origin
GENENTECH INC15 citations82
US7754441B2Jul 13, 2010
Compositions and methods for the treatment of tumor of hematopoietic origin
GENENTECH INC10 citations82
US11866496B2Jan 9, 2024
Humanized anti-CD79B antibodies and immunoconjugates and methods of use
GENENTECH INC1 citations73
US11286302B2Mar 29, 2022
Anti-B7-H4 antibodies and immunoconjugates
GENENTECH INC4 citations73
US11230600B2Jan 25, 2022
Anti-B7-H4 antibodies and immunoconjugates
GENENTECH INC3 citations73
USRE48558EMay 18, 2021
Anti-CD79B antibodies and immunoconjugates and methods of use
GENENTECH INC2 citations73
US10981987B2Apr 20, 2021
Humanized anti-CD79b antibodies and immunoconjugates and methods of use
GENENTECH INC4 citations73
US10544218B2Jan 28, 2020
Anti-CD79B antibodies and immunoconjugates and methods of use
GENENTECH INC4 citations73
US10266597B2Apr 23, 2019
Anti-CLL-1 antibodies and immunoconjugates
GENENTECH INC3 citations72
US10239947B2Mar 26, 2019
Anti-CLL-1 antibodies and immunoconjugates
GENENTECH INC1 citations72
US10227412B2Mar 12, 2019
Anti-CLL-1 antibodies and immunoconjugates
GENENTECH INC1 citations72
US9175089B2Nov 3, 2015
Anti-LGR5 antibodies and immunoconjugates
GENENTECH INC5 citations72
US11000510B2May 11, 2021
Methods of using anti-CD79b immunoconjugates
GENENTECH INC2 citations68
US12281165B2Apr 22, 2025
Anti-B7-H4 antibodies and immunoconjugates
GENENTECH INC0 citations62
US12134649B2Nov 5, 2024
Anti-B7-H4 antibodies and immunoconjugates
GENENTECH INC0 citations62
US11084877B2Aug 10, 2021
Anti-CLL-1 antibodies and immunoconjugates
GENENTECH INC0 citations62
US10941199B2Mar 9, 2021
Anti-CD79b antibodies and methods of use
GENENTECH INC0 citations62
US10556951B2Feb 11, 2020
Anti-CD33 antibodies and immunoconjugates
GENENTECH INC1 citations62
US9751946B2Sep 5, 2017
Anti-CLL-1 antibodies and immunoconjugates
GENENTECH INC1 citations62
US12016842B2Jun 25, 2024
Methods of using anti-CD79b immunoconjugates
GENENTECH INC1 citations58
CHEN YVONNE
5 patentsUS8545850B2Oct 1, 2013
Anti-CD79B antibodies and immunoconjugates and methods of use
CHEN YVONNE48 citations97
US8088378B2Jan 3, 2012
Anti-CD79B antibodies and immunoconjugates and methods of use
CHEN YVONNE48 citations97
US9845355B2Dec 19, 2017
Humanized anti-CD79b antibodies and immunoconjugates and methods of use
CHEN YVONNE20 citations92
US8722857B2May 13, 2014
Anti-CD79B antibodies and immunoconjugates and methods of use
CHEN YVONNE22 citations92
US8691531B2Apr 8, 2014
Anti-CD79B antibodies and immunoconjugates and methods of use
CHEN YVONNE20 citations92
BERIA ITALO
2 patentsUS8900589B2Dec 2, 2014
Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
BERIA ITALO23 citations90
US8389697B2Mar 5, 2013
Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
BERIA ITALO34 citations90